Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic and Translational Values of Point-of-care Blood Eosinophils and Exhaled Nitric Oxide (FeNO) in People Referred by Primary Care for Suspected Asthma (DIVE)

NCT05992519 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT05992519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05992519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic and Translational Values of Point-of-care Blood Eosinophils and Exhaled Nitric Oxide (FeNO) in People Referred by Primary Care for Suspected Asthma (DIVE)
Lead sponsor
Université de Sherbrooke
Phase
Observational
Overall status
Completed
Start date
November 7, 2022
Completion date
October 31, 2025
Enrollment
123 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, asthma in children, diagnosis, inflammation